Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Maxim submits NDA for Maxamine

July 20, 2000

Joint venture for OvaRex initiated by AltaRex in Middle East

July 14, 2000

Antisoma resumes enrollment in SMART phase III trial

July 14, 2000

Chiron reports new durable response data for Proleukin

July 13, 2000

KS Biomedix seeks approval to begin clinical trials of anticancer antibody

July 11, 2000

AltaRex establishes joint venture for OvaRex

July 6, 2000

Antigenics commences first phase III trial of its Oncophage cancer vaccine

July 6, 2000

Biomira acquires remaining rights to Theratope from Chiron

July 4, 2000

Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes

July 4, 2000

Cel-Sci receives permission to start phase II cancer trial in Canada

June 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...